Authors



Dawn Buse, PhD

Latest:

Dawn Buse, PhD: Inappropriate Prescriptions in Acute, Preventive Migraine Treatment

The clinical professor of neurology at Albert Einstein College of Medicine spoke to the findings of the OVERCOME study, and how recent literature has suggested that improper prescriptions and medication use in migraine have been ongoing in spite of the current recommendations.


Amy Sullivan, PsyD

Latest:

Amy Sullivan, PsyD: Personalized Approach to Fatigue in Multiple Sclerosis

The Director of Behavioral Medicine at the Mellen Center for MS Treatment and Research at the Cleveland Clinic spoke about how she approaches fatigue in MS from a behavioral standpoint.


Jeff Waugh, MD, PhD

Latest:

Jeff Waugh, MD, PhD: Viewing Striatal Injury More Granularly

Despite some mistrusting the abilities of imaging to aid in therapeutic development, a new MRI method could better inform the anatomical understanding of the striatum.


Patricia K. Coyle, MD

Latest:

The Role of High-Efficacy Therapies in Multiple Sclerosis Treatment: Patricia K. Coyle, MD

At the 2025 ACTRIMS Forum, the director of the MS Comprehensive Care Center at Stony Brook Medicine discussed the evolution of high-efficacy treatments for MS. [WATCH TIME: 4 minutes]



Dominic Pelle, MD

Latest:

Dominic Pelle, MD: Improving Patient-Reported Outcomes in Spine Surgery

The spine surgeon in the Center for Spine Health at Cleveland Clinic spoke to the importance of improving patient-reported outcomes and ensuring consistent communication with patients undergoing spine surgery.



James Leverenz, MD

Latest:

Promising Diagnostic Approaches Emerging for Brain Pathologies: James Leverenz, MD

The director of the Cleveland Lou Ruvo Center for Brain Health at Cleveland Clinic discussed new diagnostic techniques that show promise for advancing the understanding of brain pathologies like Alzheimer and Lewy Body diseases. [WATCH TIME: 3 minutes]


Jerrold L. Vitek, MD, PhD

Latest:

Jerrold L. Vitek, MD, PhD: Multiple Independent Contact Current-Controlled DBS Technology

The professor and head of the department of neurology at the University of Minnesota discussed what multiple independent contact current-controlled devices offer physicians conducting deep brain stimulation.


Mia Minen, MD, MPH

Latest:

Mia Minen, MD, MPH: Behavioral Therapies for Posttraumatic Headache

Mia Minen, MD, MPH, sat down for an interview to discuss why behavioral therapies could be an effective and easily accessible treatment for posttraumatic headaches following events like concussions.


Eugenia Trushina, PhD

Latest:

Eugenia Trushina, PhD: Communication and Learning Through Collaboration

For the associate professor of neurology, learning, listening, and collaborating are the keys to improving the field of care.


Chia-Chun Chiang, MD

Latest:

Narrowing Down Effective Medications, Classes of Treatments for Migraine: Chia-Chun Chiang, MD

The associate professor of neurology at Mayo Clinic Rochester discussed specific findings from a simultaneous comparison of migraine medications in which certain treatments and classes were more effective. [WATCH TIME: 3 minutes]


Ronald C. Petersen, MD, PhD

Latest:

The Potential of Blood Tests to Improve Screening and Monitoring in Alzheimer Disease Clinical Trials: Ronald C. Petersen, MD, PhD

The director of the Alzheimer’s Disease Research Center at Mayo Clinic detailed the current issues with access and affordability to critical biomarkers in the screening and monitoring of patients in Alzheimer disease trials. [WATCH TIME: 3 minutes]



David K. B. Li, MD, FRCPC

Latest:

The Importance of a Globally Aligned, Standardized MRI Protocol for MS

Leaders of the CMSC Working Group on MRI protocols and clinical guidelines express the need for a unified approach to diagnosing and monitoring multiple sclerosis.


Clive Ballard, MD

Latest:

Pimavanserin Safety Data and Future Research: Clive Ballard, MD

Clive Ballard, MD, spoke on the safety data of pimavanserin, which was presented at the 2021 AAIC meeting, held from July 26-30.


Ari Green, MD, MCR

Latest:

Ari Green, MD, MCR: Remyelination in Multiple Sclerosis

The medical director of the UCSF Multiple Sclerosis Center discussed the idea behind remyelination and shared his thoughts on what the best shot at developing a therapy might be.


Danielle Andrade, MD, MSc

Latest:

Navigating the Shift from Pediatric to Adult Care Systems in Epilepsy: Danielle Andrade, MD, MSc, FRCPC

The director of the Adult Genetic Epilepsy Program at the University of Toronto talked about the critical issues experienced by patients who transition from pediatric to adult care in epilepsy. [WATCH TIME: 9 minutes]


Xavier Montalban, MD, PhD

Latest:

Advancing Multiple Sclerosis Diagnosis With the 2024 Criteria Revision: Xavier Montalban, MD, PhD

The chair of neurology at Hospital Universitari Vall d’Hebron talked about the revision of the MS diagnostic criteria that will integrate new evidence, biological markers, and advanced MRI findings to enable earlier and more precise diagnoses. [WATCH TIME: 4 minutes]



Deborah Friedman, MD, MPH

Latest:

Deborah Friedman, MD, MPH: Coordinating Care in Telemedicine

The professor of neurology, neurotherapeutics, and ophthalmology at UT Southwestern discussed the need to better coordinate care between providers when telemedicine is being utilized in headache and migraine care.


Trevor Dyson-Hudson, MD

Latest:

Trevor Dyson-Hudson, MD: Unseen Consequences of Spinal Cord Injury

The director of the Center for Spinal Cord Injury Research and co-director of the Spinal Cord Injury Model System Center at Kessler Foundation discussed the secondary medical complications of spinal cord injury and how he and colleagues seek to alleviate them.


Aaron Boster, MD

Latest:

Treating MS: A Simplified Strategy Boosts Patient and Provider Satisfaction

Both the busy clinician and the overwhelmed patient benefit from a pointed approach to disease management.



Amit Bar-Or, MD, FRCPC

Latest:

BTKi Treatment Paradigm

Neurology experts discuss where BTKi’s fit in the multiple sclerosis treatment continuum.


Paul Newhouse, MD

Latest:

Paul Newhouse, MD: Muscarinic Agonists in Alzheimer Treatment

The Jim Turner Chair in Cognitive Disorders at the Vanderbilt University School of Medicine shared how the previous muscarinic agonists have better informed the development of this investigational agent, VU319.



Kenneth Bender, PharmD, MA

Latest:

The “Grave Threat” Posed by the Shortage of Neurologists

With the physician deficit projected to grow larger within a decade, this global challenge has become a major focus of large organizations and medical societies.


Peii Chen, PhD

Latest:

Peii Chen, PhD: Addressing Spatial Neglect After Stroke

The senior research scientist at Kessler Foundation offered her personal experience in treating spatial neglect in patients with stroke and potential future treatments on the way.

© 2025 MJH Life Sciences

All rights reserved.